Search Results - "Dalla Pria, Alessia"
-
1
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
Published in The Lancet (British edition) (27-03-2021)“…Successful phase 3 trial outcomes have been reported for numerous vaccines that induce robust humoral and cellular immune responses against the SARS-CoV-2…”
Get full text
Journal Article -
2
Prospective Stage-Stratified Approach to AIDS-Related Kaposi's Sarcoma
Published in Journal of clinical oncology (10-02-2014)“…Combination antiretroviral therapy (cART) is standard of care for patients with HIV diagnosed with Kaposi's sarcoma (KS), but the current role of systemic…”
Get full text
Journal Article -
3
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
Published in JNCI : Journal of the National Cancer Institute (11-07-2022)“…Abstract Background Fifteen percent of patients with cancer experience symptomatic sequelae, which impair post–COVID-19 outcomes. In this study, we…”
Get full text
Journal Article -
4
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study
Published in Journal of clinical oncology (01-02-2019)“…Conflicting evidence indicates that HIV seropositivity may influence the outcome of patients with hepatocellular carcinoma (HCC), a leading cause of mortality…”
Get full text
Journal Article -
5
Recent advances in HIV-associated Kaposi sarcoma [version 1; peer review: 2 approved]
Published in F1000 research (2019)“…Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the…”
Get full text
Journal Article -
6
Nannizziopsis Immune Reconstitution Inflammatory Syndrome in a Patient with HIV: First Reported Case
Published in European journal of case reports in internal medicine (23-11-2021)“…We describe the case of a 35-year-old HIV-positive male of African origin diagnosed with neurotoxoplasmosis and a spp. cavitating pulmonary lesion unmasking…”
Get full text
Journal Article -
7
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
Published in Blood advances (14-09-2021)“…Idiopathic multicentric Castleman disease (iMCD) is a poorly understood hematologic disorder involving cytokine-induced polyclonal lymphoproliferation,…”
Get full text
Journal Article -
8
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity
Published in Immunotherapy (01-05-2019)“…Immune-related hepatitis is an important toxicity from immune-checkpoint inhibitor therapy, affecting up to 20% of patients on dual cytotoxic T-lymphocyte…”
Get full text
Journal Article -
9
Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study
Published in Oncoimmunology (01-01-2017)“…Upregulation of programmed death ligand 1 (PD-L1) is a mechanism of immune escape utilized by a variety of tumors. PD-L1 expression in tumor cells or in the…”
Get full text
Journal Article -
10
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients
Published in Blood (13-04-2017)“…Successful treatment of HIV-associated multicentric Castleman disease (HIV+MCD) with rituximab-based approaches has dramatically improved survival and reduced…”
Get full text
Journal Article -
11
Indirect Human Immunodeficiency Virus Morbidity and Mortality Due to Coronavirus Disease 2019
Published in Clinical infectious diseases (16-11-2021)Get full text
Journal Article -
12
Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV coinfection
Published in AIDS (London) (13-03-2017)“…Liver-related morbidity and mortality is expanding in people living with HIV. Hepatocellular carcinoma (HCC), the third most lethal malignancy on a global…”
Get full text
Journal Article -
13
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
Published in The lancet oncology (01-12-2021)“…The medium-term and long-term impact of COVID-19 in patients with cancer is not yet known. In this study, we aimed to describe the prevalence of COVID-19…”
Get full text
Journal Article -
14
Oncological challenges for an ageing population living with HIV
Published in AIDS (London) (01-06-2017)“…Improvements in survival and changing patterns of transmission mean that the population of people living with HIV (PLWH) is ageing. Increasing age is a risk…”
Get full text
Journal Article -
15
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
Published in The lancet oncology (01-07-2022)“…The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19…”
Get full text
Journal Article -
16
High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot study
Published in AIDS (London) (27-03-2014)“…BACKGROUND:The ability to detect and treat pre-malignant anal lesions suggests screening may prevent anal cancer. The incidence of anal cancer in men who have…”
Get full text
Journal Article -
17
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae
Published in Science translational medicine (16-11-2022)“…Interstitial lung disease and associated fibrosis occur in a proportion of individuals who have recovered from severe acute respiratory syndrome coronavirus 2…”
Get more information
Journal Article -
18
The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma
Published in British journal of cancer (15-09-2015)“…Background: The prognosis of non-Hodgkin lymphoma and Hodgkin lymphoma is not affected by HIV serostatus, yet people living with HIV (PLWH) are frequently…”
Get full text
Journal Article -
19
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Published in The lancet oncology (01-04-2023)“…COVID-19 sequelae can affect about 15% of patients with cancer who survive the acute phase of SARS-CoV-2 infection and can substantially impair their survival…”
Get full text
Journal Article -
20
Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19
Published in Transplantation (01-06-2021)Get full text
Journal Article